TransMedics Group Inc. shares have had trading halted on the Nasdaq ahead of a regulatory meeting that will review one of the company's products.
The Food and Drug Administration's panel for gastroenterology and urology devices will meet at 9 a.m. ET to discuss TransMedic's liver system, a portable device designed to preserve a donated liver prior to transplant.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.